This month’s briefing covers DOJ’s approach to implementing its final rule on what’s now called the Data Security Program. The Trump ...

This article explores the global regulatory landscape, examining how leading authorities in the U.S., EU, U.K., Canada, China, Brazil, Australia, and South Korea are approaching AI in medical devices.

Quantum computing has the potential to significantly transform artificial intelligence due to its exponentially faster ...

Throughout the Middle East and beyond, health care institutions rely on robotic-assisted surgery, AI-powered diagnostics and ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial ...

Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

Mr. Yevgeniy Meshcherekov is a seasoned financial executive and Chartered Professional Accountant, bringing over 20 years of ...

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of ...

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of ...

The human touch matters when developing treatments. The Fast Company Impact Council is an invitation-only membership ...

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.